Dear Colleague,

We are excited to announce the 12th Anti-Infectives Partnering & Deal-Making Conference, which will take place July 9-10, 2015 in Boston, MA.

Over the years, the anti-infectives field has faced the same challenges in areas such as pricing and reimbursement and overcoming resistance in diseases. However, drug approvals over the past year and President Obama\’s recent proposal to spend $1.2 billion to address antimicrobial resistance are indications that the field is still changing and evolving.

We invite you to join us as we discuss and seek to answer questions such as, how can we better price antibiotics so that their value to society is better reflected and companies get a better ROI? What has caused the re-emergence of large pharmaceutical companies back into this space and how will that affect the other players? How have FDA guidelines changed and how will that change development? Leaders in the field will provide updates, and dedicated networking sessions will allow colleagues to form connections in an accessible and intimate environment.

Sessions for the meeting include:

I. Recent Deals & Advances in Anti-Infectives

II. New Government Initiatives and Non-Dilutive Funding

III. Addressing Antibiotic Resistance

IV. New Approaches to Regulatory

            V. Trends in the Anti-Infectives Marketplace

Panel discussions will also be held on the following:
I. The Re-Emergence of Big Pharma in Anti-Infectives: Cause and Effect

II. Partnering in Anti-Infectives: Best Practices and Lessons Learned

III. Diagnostics and Antibiotics

V. New Perspectives and Approaches in Antibiotics Investment

We hope to see you there!

Best regards,

The 2015 Advisory Committee